The biological role(s) proposed for UCP3 in energy homeostasis have been based primarily upon amino acid sequence homology to UCP1. Spontaneous mutations of UCP3> have been described in humans, but not in rodents. The functional consequences Ð or lack thereof Ð of these mutations in humans will be of great importance in elucidating the biology of this protein. The results of two such studies are summarized here.
Uncoupling Protein-3 (UCP3) cDNA was cloned from human skeletal muscle by three groups based upon its DNA sequence homology to UCP1. 1 ± 3 The gene was also named on the basis of this sequence homology. However, although UCP2 and UCP3 have been shown in yeast transfection studies to decrease rates of growth and mitochondrial membrane potential, 3 ± 5 the biologic functions of either molecule are not known.
UCP2 and UCP3 are 73% homologous at the amino acid level and are within 50 kb of each other on Chr 11q13, suggesting that one is the gene duplication product of the other. At this very close physical proximity, linkage studies cannot distinguish the respective contributions of either or both genes to a particular phenotype. Some linkage studies done before and after the identi®cation of these genes have found evidence of linkage of this region of the genome to phenotypes related to obesity or diabetes. 6, 7 Others have not found this relationship. 8 ± 10 There is no known spontaneous mutation of UCP3 in mice, though three groups have reported (at this conference) the production of transgenic knockouts of UCP3. The phenotypes of these knockout mice have not yet been reported. However, we have identi®ed nine sequence variants in the human UCP3 gene, including three that cause changes in highly conserved amino acids (Val9Met, Va1102I1e, Arg282Cys), and a splice site mutation in the ®rst bp of the intron between exons 6 and 7 (Ggt?Gat).
UCP3 has 7 exons, the ®rst of which is non-coding. The last exon is included in about 50% of the UCP3 mRNA synthesized in human skeletal muscle under conditions of eucaloric energy intake. 11 The ®ve (2?6) and six (2?7) exon messages are referred to as 'short' (275aa) and`long' (312aa), respectively. Rodents do not make detectable amounts of the short form of UCP3 (BB Lowell, personal communication). Based upon presumed structural homology with UCP1, the 6th coding exon should encode part of the third intracellular domain and the entire 6th transmembrane (TM) domain of the molecule. These portions of the molecule contain consensus sequences for purine nucleotide and free fatty acid (FFA) binding. In addition, the 6th TM domain may be responsible for targeting the UCP3 protein to the inner mitochondrial membrane. 12 The splice site mutation in the intron between exons 6 and 7 has been detected by us only in individuals of African-American ancestry. The other sequence variants have been detected in all ethnic groups. Homozygosity for the splice mutation eliminates the production of the long isoform of UCP3 as shown by RNAse protection assay. However, the mutation does not appear to be causally related to obesity or type II diabetes. Resting calorimetry and graded exercise studies or two subjects homozygous for the splice mutation did not show abnormalities of resting metabolic rate corrected for lean body mass, skeletal muscle work ef®ciency, or fatty acid use as fuel as re¯ected by respiratory quotient (RQ) at rest and during graded exercise. Consistent with these in vivo ®ndings, in vitro oxidative coupling of mitochondria and levels of oxidativeaglycolytic enzymes in skeletal muscle were normal. And, in a stable population of African-Americans living in Maywood, Illinois, we could detect no signi®cant linkage or association of these polymorphisms to measures of adiposity or energy expenditure, or to phenotypes related to diabetes mellitus. From these studies, we conclude that either the short isoform of UCP3 (or some other molecule) can substitute for the long isoform in functions related to these metabolic and anthropometric phenotypes, or that the function of UCP3 is not related primarily to processes related to these phenotypes. In addition, the linkage and association studies indicate that UCP2 and UCP3 do not play a signi®cant role in determining risk of obesity in the African-Americans studied. 13 Our conclusions are different from those recently reported by Argyropoulos et al.
14 in African Americans and native Africans. They also found the Va1102I1e variant in exon 3 and the exon 6a7 splice mutation, plus a single instance of an Arg143-Stop mutation. A 16 year-old with body mass index (BMI) 51.8 and type II diabetes was heterozygous for both the R143X and the exon 6 splice mutation. Three homozygotes for the splice mutation were detected in the Mende Tribe. No phenotypes are reported. Heterozygotes for this mutation were reported to have elevated RQ, at rest, but no differences in anthropometry or resting energy expenditure by indirect calorimetry. The frequency of the splice mutation was 30% in obese and 16% in lean individuals.
